The median time from G/GEJ cancer diagnosis to brain metastasis, according to HER2 status, was 10.9 and 13.1 months for HER2-positive and HER2-negative patients, respectively; there was no significant difference between the groups (p = 0.41). This evidence concerns the gene ERBB2 and cancer.